Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
A LABA (long-acting beta-agonist) inhaler is a maintenance medication that relaxes airway muscles for roughly 12 to 24 hours, taken on a daily schedule to prevent asthma or COPD symptoms rather than stop them once they start. A rescue inhaler, usually a short-acting beta-agonist like albuterol, works within minutes to open the airways during sudden wheezing, coughing, or shortness of breath, and a LABA should never be substituted for it in an emergency. There are important differences in timing, safety, and why LABAs for asthma are prescribed only in combination with an inhaled corticosteroid, so see below for the complete details before changing how you use either inhaler. Because breathing symptoms can signal anything from poorly controlled asthma to an entirely different condition, knowing what is driving yours matters for choosing the right treatment. Take a free, instant, online symptom check to better understand your symptoms and get clear guidance on what to do next.
Last reviewed for medical accuracy: 10/01/2026
Living with asthma or chronic obstructive pulmonary disease (COPD) often means navigating different inhalers and medications. Two of the main categories you’ll hear about are LABA inhalers and rescue inhalers. Understanding how they work, when to use them, and why they’re not interchangeable can help you get better symptom control and improve your quality of life.
“LABA” stands for Long-Acting Beta-Agonist. These inhalers are designed to keep your airways open for an extended period—typically 12 hours or more—by relaxing the smooth muscle lining in your bronchial tubes. Unlike rescue inhalers, they’re not meant for sudden symptom relief.
Key points about LABA inhalers:
Rescue inhalers—also called short-acting beta-agonists (SABAs)—are your “quick fix” for sudden breathing problems. You reach for these when you feel an asthma attack or a sudden flare-up coming on.
Key points about rescue inhalers:
| Feature | LABA Inhaler | Rescue Inhaler (SABA) |
|---|---|---|
| Onset of Action | 15–30 minutes | 5–10 minutes |
| Duration | 12–24 hours | 4–6 hours |
| Primary Use | Daily maintenance | Immediate relief |
| Typical Frequency | 1–2 times per day | As needed (up to a prescribed max) |
| Monotherapy? | Not recommended for asthma (alone); often combined with ICS | Effective as monotherapy for acute relief |
| Package Insert | Black-box warning if used without ICS in asthma | Generally safe for short-term relief |
Speed of Relief
Risk of Overuse
Different Treatment Goals
Like all medications, LABA inhalers can have side effects. Most are mild, but you should know what to watch for:
Common side effects:
Less common but serious (seek medical help):
If you experience any life-threatening or serious symptoms, stop using the inhaler and speak to a doctor immediately.
Keeping track of your symptoms helps you and your healthcare team fine-tune your treatment:
You might also consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on whether your current treatment plan is on track.
Always talk with your healthcare provider if you notice:
Never ignore severe or life-threatening breathing problems. If you cannot catch your breath or feel your lips/fingernails turn blue, call emergency services right away.
Your inhaler is a powerful tool in managing your lung health, but like any tool, it works best when you know how and when to use it. If you have any doubts about your treatment, dosing, or symptoms, always speak to a doctor.
(References)
* Asamoto H. [My private opinion on Asthma Prevention and Management Guideline 2009--chemotherapy plans for long term care of adult asthma patients--with special reference to handling of LABA]. Arerugi. 2010 Nov;59(11):1585-6. PMID: 21119305.
* Stynes G, Svedsater H, Wex J, Lettis S, Leather D, Castelnuovo E, Detry M, Berry S. Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy. Respir Res. 2015 Feb 15;16(1):25. doi: 10.1186/s12931-015-0184-8. Epub 2015 Feb 15. PMID: 25849223; PMCID: PMC4339422.
* Kuwahira I. [LAMA/LABA fixed dose combination for treatment of COPD]. Nihon Rinsho. 2016 May;74(5):820-6. PMID: 27254953.
* O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017 Sep;50(3):1701103. doi: 10.1183/13993003.01103-2017. Epub 2017 Sep 9. PMID: 28889114.
* Barrecheguren M, Miravitlles M. COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? No. Chest. 2018 Oct;154(4):749-751. doi: 10.1016/j.chest.2018.06.024. PMID: 30290926.
* Drugs for COPD. Med Lett Drugs Ther. 2020 Sep 7;62(1606):137-144. PMID: 32960872.
* Comparison table: Inhaled long-acting bronchodilators for treatment of COPD. Med Lett Drugs Ther. 2020 Sep 7;62(1606):e146-e147. Epub 2020 Sep 7. PMID: 32960874.
* Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY, Kim MH, Moon JY, Yang MS, Jung JW, Kim JH, Choi JH, Park CS, Kim S, Lee J, Kwon JW, Hur GY, Kim SH, Kim HK, Shin YS, Kim SH, Nam YH, Jang AS, Park SY, Kim TB, Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Study Group. A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1304-1311.e2. doi: 10.1016/j.jaip.2020.09.066. Epub 2020 Nov 9. PMID: 33184024.
* Han MK, Lipson DA, Singh D, Martinez FJ. Reply to: 'evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies'. Expert Rev Respir Med. 2021 Apr;15(4):577-578. doi: 10.1080/17476348.2021.1865813. Epub 2020 Dec 28. PMID: 33336588.
* Suissa S. Triple Therapy in COPD: Time for Adaptive Selection Trials. COPD. 2021 Dec;18(6):597-601. doi: 10.1080/15412555.2021.1982886. Epub 2021 Sep 27. PMID: 34569408.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.